Cargando…
BRMS1 Sensitizes Breast Cancer Cells to ATP-Induced Growth Suppression
Purinergic signaling may represent an effective target in cancer therapy because the expression of purinergic receptors is altered in many forms of cancer and extracellular nucleotides modulate cancer cell growth. We examined the effect of extracellular ATP on the growth of the metastatic breast car...
Autores principales: | Zhang, Yue, Chin-Quee, Karis, Riddle, Ryan C., Li, Zhongyong, Zhou, Zhiyi, Donahue, Henry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620472/ https://www.ncbi.nlm.nih.gov/pubmed/23593560 http://dx.doi.org/10.1089/biores.2012.0260 |
Ejemplares similares
-
MDA-MET-conditioned-medium augments the chemoattractant-dependent migration of MDA-MET cells towards hFOB-conditioned medium and increases collagenase activity
por: Chin-Quee, Karis, et al.
Publicado: (2017) -
BRMS1 in Gliomas—An Expression Analysis
por: Feldheim, Jonas, et al.
Publicado: (2023) -
Identification of BRMS1L as Metastasis Suppressing Gene in Esophageal Squamous Cell Carcinoma
por: Zhou, Ruihao, et al.
Publicado: (2020) -
BRMS1 gene expression may be associated with clinico-pathological features of breast cancer
por: Lin, Li-Zhong, et al.
Publicado: (2017) -
BRMS1 Suppresses Glioma Progression by Regulating Invasion, Migration and Adhesion of Glioma Cells
por: Mei, Pengjin, et al.
Publicado: (2014)